The Maximum Effect of an Increase in Rate on Human Ventricular Refractoriness
dc.contributor.author | Morady, Fred | en_US |
dc.contributor.author | Kadish, Alan H. | en_US |
dc.contributor.author | Toivonen, Lauri K. | en_US |
dc.contributor.author | Kushner, Jeffrey A. | en_US |
dc.contributor.author | Schmaltz, Stephen P. | en_US |
dc.date.accessioned | 2010-06-01T21:34:38Z | |
dc.date.available | 2010-06-01T21:34:38Z | |
dc.date.issued | 1988-12 | en_US |
dc.identifier.citation | MORADY, FRED; KADISH, ALAN H.; TOIVONEN, LAURI K.; KUSHNER, JEFFREY A.; SCHMALTZ, STEPHEN (1988). "The Maximum Effect of an Increase in Rate on Human Ventricular Refractoriness." Pacing and Clinical Electrophysiology 11(12): 2223-2234. <http://hdl.handle.net/2027.42/74629> | en_US |
dc.identifier.issn | 0147-8389 | en_US |
dc.identifier.issn | 1540-8159 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/74629 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=2463610&dopt=citation | en_US |
dc.format.extent | 891564 bytes | |
dc.format.extent | 3109 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Blackwell Publishing Ltd | en_US |
dc.rights | 1988 Official journal of the International Cardiac Pacing and Electrophysiology Society | en_US |
dc.subject.other | Ventricular Refractoriness | en_US |
dc.subject.other | Autonomic Blockade | en_US |
dc.subject.other | Drive Train Duration | en_US |
dc.title | The Maximum Effect of an Increase in Rate on Human Ventricular Refractoriness | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Physiology | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Division of Cardiology and the Clinical Research Center, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, MI | en_US |
dc.identifier.pmid | 2463610 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/74629/1/j.1540-8159.1988.tb05989.x.pdf | |
dc.identifier.doi | 10.1111/j.1540-8159.1988.tb05989.x | en_US |
dc.identifier.source | Pacing and Clinical Electrophysiology | en_US |
dc.identifier.citedreference | Gibbs GL, Johnson EA. Effect of changes in frequency of stimulation upon rabbit ventricular action potential. Circ Res 1981; 9: 165 – 170. | en_US |
dc.identifier.citedreference | Mendez G, Gruhzit G, Moe G. Influence of cycle length upon refractory period of auricles, ventricles and A-V node in the dog. Am J Physiol 1956; 184: 287 – 295. | en_US |
dc.identifier.citedreference | Denes P, Wu D, Dhingra R, et al. The effects of cycle length on cardiac refractory periods in man. Circulation 1974; 49: 32 – 41. | en_US |
dc.identifier.citedreference | Guss S, Kastor J, Josephson M, et al. Human ventricular refractoriness. Circulation 1976; 53: 450 – 456. | en_US |
dc.identifier.citedreference | Janse MJ, van der Steen ABM, van Dam RTh, et al. Refractory period of the dog's ventricular myocardium following sudden changes in frequency. Circ Res 1969; 24: 251 – 262. | en_US |
dc.identifier.citedreference | Vick RL. Action potential duration in canine Purkinje tissue: Effects of preceding excitation. J Electrocardiol 1971; 4: 105 – 115. | en_US |
dc.identifier.citedreference | Miller JP, Wallace AG, Feezor MD. A quantitative comparison of the relation between the shape of the action potential and the pattern of stimulation in canine ventricular muscle and Purkinje fibers. J Mol Cell Cardiol 1971; 2: 3 – 19. | en_US |
dc.identifier.citedreference | Boyett MR. An analysis of the effect of the rate of stimulation and adrenaline on the duration of the cardiac action potential. Pfluger Archiv 1978; 377: 155 – 166. | en_US |
dc.identifier.citedreference | Lab MJ, Yardley J. Electrophysiological differences between apex and base in intact pig ventricle. J Physiol 1979; 292: 62P – 63P. | en_US |
dc.identifier.citedreference | Boyett MR, Jewell BR. Analysis of the effects of changes in rate and rhythm upon electrical activity in the heart. Prog Biophysiol Mol Biol 1980; 36: 1 – 52. | en_US |
dc.identifier.citedreference | Prystowsky EN, Miles WM. Human ventricular refractoriness: Interdependency of drive train duration, current strength and heart rate, (abstract) J Am Cell Cardiol 1984; 3: 537. | en_US |
dc.identifier.citedreference | Brownstein SL, Bauernfeind R, Welch W, et al. Cumulative effects of cycle length on ventricular refractoriness in man. ( abstract ) PAGE 1987; 10: 432. | en_US |
dc.identifier.citedreference | Livelli FD, Jr., Bigger JT, Feiffel JA, et al. Response to programmed ventricular stimulation: Sensitivity, specificity and relation to heart disease. Am J Gardiol 1982; 50: 452 – 458. | en_US |
dc.identifier.citedreference | Swiryn S, Bauernfeind RA, Strasberg B, et al. Prediction of response to class I antiarrhythmic drugs during electrophysiologic study of ventricular tachycardia. Am Heart J 1982; 104: 43 – 50. | en_US |
dc.identifier.citedreference | DiMarco JP, Garan H, Ruskin JN. Quinidine for ventricular arrhythmias: Value of electrophysiologic testing. Am J Gardiol 1983; 51: 90 – 95. | en_US |
dc.identifier.citedreference | Marchlinski FE, Buxton AE, Vassallo JA, et al. Comparative electrophysiologic effects of intravenous and oral procainamide in patients with sustained ventricular arrhythmias. J Am Coll Cardiol 1984; 4: 1247 – 1254. | en_US |
dc.identifier.citedreference | Estes NAM, Garan H, McGovern B, et al. Influence of drive cycle length during programmed stimulation on induction of ventricular arrhythmias: Analysis of 403 patients. Am J Cardiol 1986; 57: 108 – 112. | en_US |
dc.identifier.citedreference | Morady F, DiCarlo LA, Jr., de Buitlier M, et al. Effects of incremental doses of procainamide on ventricular refractoriness, intraventricular conduction and induction of ventricular tachycardia. Circulation 1986; 74: 1355 – 1364. | en_US |
dc.identifier.citedreference | Naccarelli GV, Prystowsky EN, Jackman WM, et al. Role of electrophysiologic testing in managing patients who have ventricular tachycardia unrelated to coronary artery disease. Am J Cardiol 1982; 50: 165 – 171. | en_US |
dc.identifier.citedreference | Denker S, Lehmann M, Mahnud R, et al. Facilitation of ventricular tachycardia induction with abrupt changes in ventricular cycle length. Am J Cardiol 1984; 53: 508 – 515. | en_US |
dc.identifier.citedreference | Buston AE, Waxman HL, Marchhnski FE, et al. Role of triple extrastimuli during electrophysiologic study of patients with documented sustained ventricular tachyarrhythmias. Circulation 1984; 69: 532 – 540. | en_US |
dc.identifier.citedreference | Brugada P, Wellens HJJ. Comparison in the same patient of two programmed ventricular stimulation protocols to induce ventricular tachycardia. Am J Cardiol 1985; 55: 380 – 383. | en_US |
dc.identifier.citedreference | Herre JM, Mann DE, Luck JG, et al. Effect of increased current, multiple pacing sites and number of extrastimuli on induction of ventricular tachycardia. Am J Cardiol 1986; 56: 102 – 107. | en_US |
dc.identifier.citedreference | Morady F, DiCarlo LA, Jr., Baerman JM, et al. Comparison of coupling intervals that induce clinical and nonclinical forms of ventricular tachycardia during programmed stimulation. Am J Cardiol 1986; 57: 1269 – 1273. | en_US |
dc.identifier.citedreference | Jose AD, Taylor RR. Autonomic blockade by propranoiol and atropine to study intrinsic myocardial function in man. J Clin Invest 1969; 48: 2019 – 2031. | en_US |
dc.identifier.citedreference | Schneck DW, Pritchard JF, Hayes AH. Measurement of propranoiol, 4-hydroxypropranolol, and propranolol glycol in human plasma. Res Commun Chem Pathol Pharmacol 1979; 24: 3 – 12. | en_US |
dc.identifier.citedreference | Reddy GP, Gettes LS. Use of isoproterenol as an aid to electric induction of chronic recurrent ventricular tachycardia. Am J Cardiol 1979; 44: 705 – 713. | en_US |
dc.identifier.citedreference | Freedman RA, Swerdlow GD, Echt DS, et al. Facilitation of ventricular tachyarrhythmia induction by isoproterenol. Am J Cardiol 1984; 54: 765 – 770. | en_US |
dc.identifier.citedreference | Olshansky B, Martins JB. Usefulness of isproterenol facilitation of ventricular tachycardia induction during estrastimulus testing in predicting effective chronic therapy with beta-adrenergic blockade. Am J Cardiol 1987; 59: 573 – 577. | en_US |
dc.identifier.citedreference | Prystowsky EN, Jackman WM, Rinkenberger RL, et al. Effect of autonomic blockade on ventricular refractoriness and atrioventricular nodal conduction in humans. Evidence supporting a direct cholinergic action on ventricular muscle refractoriness. Girc Res 1981; 49: 511 – 518. | en_US |
dc.identifier.citedreference | Morady F, Kou WH, Nelson SD, et al. Accentuated antagonism between beta-adrenergic and vagal effects on ventricular refractoriness in humans. Circulation 1988; 77: 289 – 297. | en_US |
dc.identifier.citedreference | Wiener I, Kunkes S, Rubin D, et al. Effects of sudden change in cycle length on human atrial, atrioventricular nodal and ventricular refractory periods. Circulation 1981; 64: 245 – 248. | en_US |
dc.identifier.citedreference | Morady F, Nelson SD, Kou WH, et al. The electro-physiologic effects of epinephrine in humans. J Am Coll Cardiol 1988; 11: 1235 – 44. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.